Please provide your email address to receive an email when new articles are posted on . The introduction of long-acting injectable cabotegravir PrEP in sub-Saharan Africa could result in fewer future ...
Expansion of antiretroviral therapy in Uganda sharply reduced orphanhood incidence, especially among adolescents, but ...
A groundbreaking discovery reveals how HIV integrates its genetic material into human DNA, exposing a key viral vulnerability that could lead to new therapies and bring the world closer to a ...
Many HIV-serodiscordant couples desire children and physician-assisted techniques can help individuals achieve pregnancy while reducing the risk of seroconversion in their seronegative partner. For ...
Campaigners in Northern Ireland have called for the introduction of a 'game-changing' drug that will prevent HIV. On Friday it was announced cabotegravir (CAB-LA) injections will be introduced in ...
Lenacapavir, a long-acting injectable PrEP, requires two injections annually, marking a significant advancement in HIV ...
You may not realize you’ve benefited from HIV research. But if you’ve received a treatment that was approved through a recent clinical trial, received a CAR T cell for your cancer, or even just taken ...
Opinion
The Daily Monitor on MSNOpinion

Complacency derails HIV fight, say health experts

Experts and activists have warned that complacency may cause a resurgence of the epidemic that has claimed more than 40 million people. A number of young people do not think HIV is not a problem ...